Neurological events related to influenza A (H1N1) pdm09
Open Access
- 13 February 2014
- journal article
- review article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 8 (3) , 339-346
Abstract
Objectives: To review neurological complications after the influenza A (H1N1) pdm09, highlighting the clinical differences between patients with post‐vaccine or viral infection.Design: A search on Medline, Ovid, EMBASE, and PubMed databases using the keywords “neurological complications of Influenza AH1N1” or “post‐vaccine Influenza AH1N1.”Setting: Only papers written in English, Spanish, German, French, Portuguese, and Italian published from March 2009 to December 2012 were included.Sample: We included 104 articles presenting a total of 1636 patient cases. In addition, two cases of influenza vaccine‐related neurological events from our neurological care center, arising during the period of study, were also included.Main outcome measures: Demographic data and clinical diagnosis of neurological complications and outcomes: death, neurological sequelae or recovery after influenza A (H1N1) pdm09 vaccine or infection.Results: The retrieved cases were divided into two groups: the post‐vaccination group, with 287 patients, and the viral infection group, with 1349 patients. Most patients in the first group were adults. The main neurological complications were Guillain‐Barre syndrome (GBS) or polyneuropathy (125), and seizures (23). All patients survived. Pediatric patients were predominant in the viral infection group. In this group, 60 patients (4.7%) died and 52 (30.1%) developed permanent sequelae. A wide spectrum of neurological complications was observed.Conclusions: Fatal cases and severe, permanent, neurological sequelae were observed in the infection group only. Clinical outcome was more favorable in the post‐vaccination group. In this context, the relevance of an accurate neurological evaluation is demonstrated for all suspicious cases, as well as the need of an appropriate long‐term clinical and imaging follow‐up of infection and post‐vaccination events related to influenza A (H1N1) pdm09, to clearly estimate the magnitude of neurological complications leading to permanent disability.Keywords
This publication has 125 references indexed in Scilit:
- Pandemic A/H1N1v influenza 2009 in hospitalized children: a multicenter Belgian surveyBMC Infectious Diseases, 2011
- Pandemic (H1N1) 2009 Encephalitis in Woman, TaiwanEmerging Infectious Diseases, 2011
- Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort StudyClinical Infectious Diseases, 2011
- Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled AnalysisPLOS Medicine, 2011
- Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)Archives of Neurology, 2011
- Hypothalamic abnormalities and Parkinsonism associated with H1N1 influenza infectionJournal of Neuroinflammation, 2010
- Depressive symptoms predict exaggerated inflammatory responses to an in vivo immune challenge among pregnant womenBrain, Behavior, and Immunity, 2010
- Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenzaCanadian Medical Association Journal, 2009
- Ocular Infection of Mice with Influenza A (H7) Viruses: a Site of Primary Replication and Spread to the Respiratory TractJournal of Virology, 2009
- Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1β and anti-inflammatory IL-10 cytokinesBrain, Behavior, and Immunity, 2009